“Oral Nalbuphine Extended-Release Is Effective in Severe Prurigo Nodularis–Associated Pruritus: Results From a Phase 2b 3, Double-Blind, Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s103, https://doi.org/10.25251/skin.6.supp.103.